DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	LCE2B; KRT34; GJB5; KRT14; SPRR1B; SPRR2E; S100A7; CASP14; SPRR1A; SPRR2B; SPRR2A; KRT9; KLK7; KRT31; CERS3; ACER1; SPRR2F; SPRR2G; CALML5; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	23	82	28.0487804878049	0	0	0	0	0	0	0
down	KRT34; KRT37; KRT75; KRT14; KRT6B; KRT1; IVL; KRT16; KRT10; PI3; SPRR1B; SPRR2E; CASP14; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT20; KRT6C; KRT76; KRT17; KRT33B; KRT31; LCE1A; LIPK; LIPM; SPINK6; KRT27; CERS3; SPRR2F; LCE3D; SPRR2G; SPRR3; KLK13; KLK5;	GO:0070268~cornification	35	113	30.9734513274336	0	0	0	0	0	0	0
down	ID4; FOXG1; ISL1; HES5; ISL2; NR2E1;	GO:0045665~negative regulation of neuron differentiation	6	59	10.1694915254237	0.00015695706691953	0.00695322564201269	0.268239627365491	0.274047038841514	0.222251206758067	0.268239627365491	0.0559219064617557
down	EPCAM; WT1; LHX1; NPNT; FOXC2;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00016727404343097	0.00695322564201269	0.285704066180107	0.292060479830484	0.230670905891316	0.285704066180107	0.0559219064617557
down	MUC3A; MUC21; MUC17; MUC16; MUCL1; MUC13;	GO:0016266~O-glycan processing	6	60	10	0.0001708583214276	0.00695322564201269	0.291655154676918	0.298318629212594	0.233563325391533	0.291655154676918	0.0559219064617557
down	ALOX12B; PSAPL1; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.00017124209771279	0.00695322564201269	0.292139018698034	0.298988702606546	0.233868282000299	0.291796534502608	0.0559219064617557
down	DLX2; DLX3; DLX5; DLX6;	GO:0009790~embryo development	4	19	21.0526315789474	0.00017124209771279	0.00695322564201269	0.292139018698034	0.298988702606546	0.233868282000299	0.291796534502608	0.0559219064617557
down	CYP26A1; LRAT; CYP1A1; GATA4;	GO:0033189~response to vitamin A	4	19	21.0526315789474	0.00017124209771279	0.00695322564201269	0.292139018698034	0.298988702606546	0.233868282000299	0.291796534502608	0.0559219064617557
down	PIGR; KRT1; AZGP1; PRDX1; ZG16B;	GO:0001895~retina homeostasis	5	40	12.5	0.00023301241156725	0.00924635614991889	0.396820136899039	0.406839670596431	0.282411042819516	0.396820136899039	0.0743646028979107
down	CYP1A1; WT1; VAX1; HES5; FOXC2;	GO:0043010~camera-type eye development	5	42	11.9047619047619	0.00028665435233499	0.010997121323797	0.487885707674156	0.500498499176896	0.320532744223609	0.487885707674156	0.0884452801735833
down	SULT1C2; CYP1A1; AOC1;	GO:0009308~amine metabolic process	3	8	37.5	0.00028972942777472	0.010997121323797	0.4928297566448	0.505867580894663	0.322758582541039	0.4928297566448	0.0884452801735833
down	HOXC11; FGF1; HOXA11;	GO:0001759~organ induction	3	10	30	0.00049299741082775	0.0163132100130385	0.836616606174701	0.860773479305261	0.419047799203592	0.835630611353046	0.131200373957094
down	ID4; HES5; NR2E1;	GO:0048712~negative regulation of astrocyte differentiation	3	10	30	0.00049299741082775	0.0163132100130385	0.836616606174701	0.860773479305261	0.419047799203592	0.835630611353046	0.131200373957094
down	HOXD9; HOXD10; ISL2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.00049299741082775	0.0163132100130385	0.836616606174701	0.860773479305261	0.419047799203592	0.835630611353046	0.131200373957094
down	HOXB8; HOXD9; HOXD10; EN1; DMBX1;	GO:0008344~adult locomotory behavior	5	48	10.4166666666667	0.00050453226844449	0.0163132100130385	0.854677662744967	0.880913340704081	0.423807105493372	0.854173130476523	0.131200373957094
down	LHX1; EN1; CDK5R2; FAIM2; GBX2;	GO:0021549~cerebellum development	5	48	10.4166666666667	0.00050453226844449	0.0163132100130385	0.854677662744967	0.880913340704081	0.423807105493372	0.854173130476523	0.131200373957094
up	RNASE2; CCL2; FPR1; CXCR2; FPR3; FPR2; PTAFR; CX3CR1; CCR6; NCKAP1L; CCL7; PROK2; C5AR2; PTGDR2; CCR3; CXCR3; CCR8; FES; CXCR5; CCR7; CCR2; CCR5;	GO:0006935~chemotaxis	22	122	18.0327868852459	0.00057191514870058	0.125145432992937	1	1	0.999999999999988	0.999999999999988	1
up	CARD11; TRAV2; IGKV3-11; IGLV2-14; TRDV2; VPREB3; IGKV3-20; IGKV4-1; TRAV14DV4; IGLV2-11; TRDV1; IGLV1-40; TRAV38-2DV8; TRAV18; IGKV1-5; TRAV40; TRAV38-1; TRAV9-2; TRAV19; IGKV3-15;	GO:0002377~immunoglobulin production	20	107	18.6915887850467	0.00067290607943904	0.134973744434147	1	1	0.999999999999988	0.999999999999988	1
down	SOX18; FLT4; FOXC2;	GO:0001946~lymphangiogenesis	3	12	25	0.00076996329347678	0.0235851914107099	1	1	0.513169826357743	0.990430704160585	0.189685900595992
down	LHX1; FAIM2; LHX5;	GO:0021702~cerebellar Purkinje cell differentiation	3	12	25	0.00076996329347678	0.0235851914107099	1	1	0.513169826357743	0.990430704160585	0.189685900595992
down	LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	4	30	13.3333333333333	0.00080514570534295	0.0238268542632001	1	1	0.524954999883608	0.990430704160585	0.191629494566333
down	CAPN8; PRSS3; CTRB2; CYP39A1;	GO:0007586~digestion	4	30	13.3333333333333	0.00080514570534295	0.0238268542632001	1	1	0.524954999883608	0.990430704160585	0.191629494566333
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; INPP5D; CD300A;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.00082250718262344	0.141412484898188	1	1	0.999999999999988	0.999999999999988	1
down	CDK5R2; CDKN3; CCNB2; CCNO; CCNB1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	5	55	9.09090909090909	0.0008943757598967	0.0250454364699765	1	1	0.547357965056783	0.990430704160585	0.201430045230411
down	HOXC11; HOXA11; HOXD12; HOXD13; ALX4;	GO:0042733~embryonic digit morphogenesis	5	55	9.09090909090909	0.0008943757598967	0.0250454364699765	1	1	0.547357965056783	0.990430704160585	0.201430045230411
down	CA2; KRT14; GGH; SLC30A3;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.00090018878138742	0.0250454364699765	1	1	0.548590885340485	0.990430704160585	0.201430045230411
down	CLDN5; RAMP2; CEACAM1;	GO:0043116~negative regulation of vascular permeability	3	13	23.0769230769231	0.00093894565073837	0.0252215247106032	1	1	0.556794770887857	0.990430704160585	0.202846249827863
down	ID4; DLX2; HES5;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.00093894565073837	0.0252215247106032	1	1	0.556794770887857	0.990430704160585	0.202846249827863
down	FGF1; ADRA2C; NTF3; DYNAP;	GO:0032148~activation of protein kinase B activity	4	32	12.5	0.00100286098873803	0.0265302316111606	1	1	0.56983598352033	0.990430704160585	0.213371635979095
down	PLA2G2A; NKX2-1; PLA2G4E; PLPPR5; PLA2G2F;	GO:0006644~phospholipid metabolic process	5	57	8.7719298245614	0.00103843156543282	0.0266632575477309	1	1	0.577367950380647	0.990430704160585	0.214441508346953
down	DLX3; CA2; BMP2; DLX2; AMTN;	GO:0042475~odontogenesis of dentin-containing tooth	5	57	8.7719298245614	0.00103843156543282	0.0266632575477309	1	1	0.577367950380647	0.990430704160585	0.214441508346953
down	HOXD9; HOXA11; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	4	33	12.1212121212121	0.00111348660929678	0.0281760524613358	1	1	0.592909834241434	0.990430704160585	0.22660828963811
down	RAMP2; WT1; SOX18; FOXF1; RASIP1;	GO:0001570~vasculogenesis	5	60	8.33333333333333	0.00128584940417342	0.0313334913344001	1	1	0.627125186003658	0.990430704160585	0.252002259344967
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.00134319109725167	0.0313334913344001	1	1	0.635329389000041	0.990430704160585	0.252002259344967
up	S1PR4; OXT; CALCA; EDNRB; CD52; GLP1R; PROK2; TRPC5; FPR2; PTGDR; FPR3; CXCR2; CXCR3; CCR7; CCR8; PTGER2; CCR6; CCR5; FPR1; CXCR5; CCR2; CCR3; C5AR2; CX3CR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	24	150	16	0.00144955113936795	0.210670121528382	1	1	0.999999999999988	0.999999999999988	1
down	KRT1; ELANE; SAA1; ISL1; TNFAIP6; FOXF1;	GO:0050728~negative regulation of inflammatory response	6	93	6.45161290322581	0.0014947992601021	0.0313334913344001	1	1	0.656825103737893	0.990430704160585	0.252002259344967
down	DSCAM; CDH16; CEACAM5; CEACAM1; PCDHB8; PCDHA11; PCDHAC2; VSTM2L;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	8	165	4.84848484848485	0.00150745319134571	0.0313334913344001	1	1	0.658757044618075	0.990430704160585	0.252002259344967
up	HP; HPR; JCHAIN; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-14; IGLV2-11; IGKC; IGHA2; IGKV3-11; ITGB2; IGKV4-1; IGHV4-34; ASGR1; CD14; IGLC2; IGLC3; ITGAM; FPR2; FCGR2B; HBB; FCGR1B; STAB1;	GO:0006898~receptor-mediated endocytosis	25	160	15.625	0.00156504235954513	0.210670121528382	1	1	0.999999999999988	0.999999999999988	1
up	CD19; CD27; FCGR2B; INPP5D; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	6	13	46.1538461538462	0.00157543090465762	0.210670121528382	1	1	0.999999999999988	0.999999999999988	1
up	NCF1; CD52; SLC11A1; NCF4; NCF1B; NCF1C;	GO:0045730~respiratory burst	6	13	46.1538461538462	0.00157543090465762	0.210670121528382	1	1	0.999999999999988	0.999999999999988	1
down	CDC20; KNDC1; CSMD3;	GO:0050773~regulation of dendrite development	3	16	18.75	0.00158042120884783	0.0324637109488036	1	1	0.668979874340872	0.990430704160585	0.261092146371791
down	HOXC13; SOX18; LHX2; ALX4;	GO:0001942~hair follicle development	4	37	10.8108108108108	0.00164198971615925	0.032953034993265	1	1	0.678141752773772	0.990430704160585	0.265027576466066
down	AGR2; FOXF1; EGFLAM; NPNT;	GO:0010811~positive regulation of cell-substrate adhesion	4	37	10.8108108108108	0.00164198971615925	0.032953034993265	1	1	0.678141752773772	0.990430704160585	0.265027576466066
up	ARPC1B; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-14; IGLV2-11; IGKC; IGHG2; IGKV3-11; IGKV4-1; IGHV4-34; HCK; CD3G; FGR; IGLC2; IGLC3; FCGR2A; CD247; FCGR2B; NCKAP1L; CYFIP2;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	22	135	16.2962962962963	0.0018212636946473	0.230725353316634	1	1	0.999999999999988	0.999999999999988	1
down	CA2; KRT16; SERPINB5;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.00184228960496846	0.0365527005713061	1	1	0.703520582474822	0.990430704160585	0.293978191923232
down	BMP2; LHX1; HES5;	GO:0021537~telencephalon development	3	18	16.6666666666667	0.0021296646723219	0.0395931848213883	1	1	0.736863976623376	0.990430704160585	0.318431544163693
down	LHX2; DLX2; NR2E1;	GO:0021772~olfactory bulb development	3	18	16.6666666666667	0.0021296646723219	0.0395931848213883	1	1	0.736863976623376	0.990430704160585	0.318431544163693
down	KRT9; KRT20; KRT17;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.0021296646723219	0.0395931848213883	1	1	0.736863976623376	0.990430704160585	0.318431544163693
down	NPNT; NMU; ADRA1B;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.0021296646723219	0.0395931848213883	1	1	0.736863976623376	0.990430704160585	0.318431544163693
down	WT1; DLX5; DLX6; ACTL8; DLX3;	GO:0030855~epithelial cell differentiation	5	68	7.35294117647059	0.00215667622563287	0.0395931848213883	1	1	0.739739945392074	0.990430704160585	0.318431544163693
down	CD9; NKX2-1; FOXG1; DLX2; VAX1; HES5; DMBX1; EMX2; ADGRL2;	GO:0007420~brain development	9	217	4.14746543778802	0.00219345153189299	0.0395931848213883	1	1	0.743580069311723	0.990430704160585	0.318431544163693
up	ACOD1; NCR3; MEFV; PSTPIP1; IL18RAP; LY86; CALCA; ITGB2; HCK; CCL2; ITGAL; CXCR2; PTAFR; CD40LG; FCGR2B; CCR7; CNR2; SLC11A1; CXCR3; AIF1; NLRP6; ADAM8; FUT7; NAIP; NLRP9; NFAM1; PLD4; KLRG1; CD180; IL22; PROK2; MMP25; STAB1; LY96; CD14; CCR3; PTGDR; PPBP; CCL7; FPR1; CCR5; PTGER2; FPR3; C5AR2; CCR2; FPR2; IL2RA;	GO:0006954~inflammatory response	47	381	12.3359580052493	0.00225677884996789	0.271603334593635	1	1	0.999999999999988	0.999999999999988	1
down	CLDN1; SLPI; CYP1A1; ELANE; IDO1; MAOB; S100A7;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.00230082604810788	0.0401724227999637	1	1	0.756678468336917	0.990430704160585	0.323090114692638
down	EN2; ISL1; EN1; GRIK2; VSTM2L; FAIM2; NTF3;	GO:0043524~negative regulation of neuron apoptotic process	7	138	5.07246376811594	0.00230082604810788	0.0401724227999637	1	1	0.756678468336917	0.990430704160585	0.323090114692638
down	PLA2G2A; PLA2G4E; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.0024433709420697	0.0422388679688485	1	1	0.772105217694025	0.990430704160585	0.339709675079761
down	BMP2; SERPINB3; ISL1; ALX1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	4	42	9.52380952380952	0.00252010052354978	0.0431381913148816	1	1	0.778711061776883	0.990430704160585	0.346942559301419
down	DLX3; CEACAM1; GJA4; FOXF1;	GO:0001568~blood vessel development	4	43	9.30232558139535	0.00272786295805971	0.0457966223535794	1	1	0.793808120795376	0.990430704160585	0.368323216213058
down	IDO1; VTCN1; PLA2G2F; PLA2G2A;	GO:0042130~negative regulation of T cell proliferation	4	43	9.30232558139535	0.00272786295805971	0.0457966223535794	1	1	0.793808120795376	0.990430704160585	0.368323216213058
up	IFNG; ITGB2; ITGAM; FPR2; SNCA; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	8	27	29.6296296296296	0.00272853767739512	0.312742389975716	1	1	0.999999999999988	0.999999999999988	1
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.00278419026871624	0.045860341596024	1	1	0.797798005526963	0.990430704160585	0.368835683620166
down	CCL21; CLDN7; EPCAM;	GO:2000147~positive regulation of cell motility	3	20	15	0.00278419026871624	0.045860341596024	1	1	0.797798005526963	0.990430704160585	0.368835683620166
down	AKR1B15; AKR1B10; LRAT; CYP1A1;	GO:0042572~retinol metabolic process	4	44	9.09090909090909	0.00294705536008644	0.0479037430206521	1	1	0.80962920438684	0.990430704160585	0.385269912741313
down	CCL21; CXCL14; SAA2; SAA1; DEFB4A;	GO:0060326~cell chemotaxis	5	74	6.75675675675676	0.00304607157167813	0.0479037430206521	1	1	0.81634718120974	0.990430704160585	0.385269912741313
down	TCN1; PRSS3; CTRB2;	GO:0009235~cobalamin metabolic process	3	21	14.2857142857143	0.00315286298378159	0.0479037430206521	1	1	0.822897238766995	0.990430704160585	0.385269912741313
down	PLA2G2A; PLA2G4E; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	3	21	14.2857142857143	0.00315286298378159	0.0479037430206521	1	1	0.822897238766995	0.990430704160585	0.385269912741313
down	CYP1A1; BMP2; CCNB1; FOXF1;	GO:0071407~cellular response to organic cyclic compound	4	45	8.88888888888889	0.00317797848151724	0.0479037430206521	1	1	0.824100769998424	0.990430704160585	0.385269912741313
down	ALOX12B; BMP2; ADRA2C; EPHA8; ADRA1B; FLT4;	GO:0043410~positive regulation of MAPK cascade	6	109	5.5045871559633	0.00318126040612432	0.0479037430206521	1	1	0.824100769998424	0.990430704160585	0.385269912741313
down	SERPINB5; FOXF1; FOXF2; EGFLAM; NPNT; NR2E1; MMP12; MMP13; MMP7;	GO:0030198~extracellular matrix organization	9	230	3.91304347826087	0.00318260835646944	0.0479037430206521	1	1	0.824295564325585	0.990430704160585	0.385269912741313
down	SAA1; DPEP1; CCL21; CXCL10; CXCL11;	GO:0030593~neutrophil chemotaxis	5	76	6.57894736842105	0.00339386870871972	0.0501927979930779	1	1	0.836745702448136	0.990430704160585	0.403679831337995
down	TCF15; FOXF1; FOXC2; HES7;	GO:0001756~somitogenesis	4	46	8.69565217391304	0.00342092953102879	0.0501927979930779	1	1	0.838127735102054	0.990430704160585	0.403679831337995
down	CYP26A1; LRAT; TRIML2; RXRG;	GO:0032526~response to retinoic acid	4	46	8.69565217391304	0.00342092953102879	0.0501927979930779	1	1	0.838127735102054	0.990430704160585	0.403679831337995
down	CCNB1; CCNO; CCNB2;	GO:0044772~mitotic cell cycle phase transition	3	22	13.6363636363636	0.00355008902458409	0.0516537953076985	1	1	0.845430024946535	0.990430704160585	0.415430026049847
down	MUC3A; MUC21; MUC17; MUC16; MUCL1; MUC13;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	6	112	5.35714285714286	0.00361206047590301	0.0521211371150963	1	1	0.848887897739086	0.990430704160585	0.419188662139701
down	CYP39A1; CYP26A1; CYP26C1;	GO:0016125~sterol metabolic process	3	23	13.0434782608696	0.00397652903897239	0.0539748657062356	1	1	0.86688333049598	0.990430704160585	0.434097431424105
up	ITGB2; ALOX5; CCR6; ADAM8; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.00411772592202531	0.43092896931804	1	1	0.999999999999988	0.999999999999988	1
down	NKX2-8; FGF1; NKX2-1; FOXF1; LHX3;	GO:0030324~lung development	5	80	6.25	0.00417359524346272	0.0543813230976561	1	1	0.876455001127172	0.990430704160585	0.437366399438945
down	DEFB4A; S100A7; LCE3A; NLRP10; DEFB126;	GO:0050829~defense response to Gram-negative bacterium	5	80	6.25	0.00417359524346272	0.0543813230976561	1	1	0.876455001127172	0.990430704160585	0.437366399438945
down	PLA2G2A; LIPK; LIPM; PLA2G2F; PNLIPRP3;	GO:0016042~lipid catabolic process	5	81	6.17283950617284	0.00438691691605331	0.0567374587809561	1	1	0.885857149681535	0.990430704160585	0.456315820337441
up	TRPM2; CXCR2; CCR7; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	6	17	35.2941176470588	0.00458161970723248	0.45949827647119	1	1	0.999999999999988	0.999999999999988	1
down	FGF1; REG1A; EPB41L4B; CCM2L; SPRR3;	GO:0042060~wound healing	5	82	6.09756097560976	0.00460788858304406	0.0587253537663864	1	1	0.894284057143075	0.990430704160585	0.472303634217567
down	LMX1B; CCNB2; BMP2; CCNB1; SOX18; FOXF1; PTPRR; FOXD3;	GO:0001701~in utero embryonic development	8	203	3.94088669950739	0.00507416473583078	0.0630927093958531	1	1	0.909515681066959	0.990430704160585	0.507428461969535
down	CERS1; FA2H; CERS3; ACER1;	GO:0030148~sphingolipid biosynthetic process	4	52	7.69230769230769	0.00514737351418981	0.0630927093958531	1	1	0.911402083961024	0.990430704160585	0.507428461969535
down	PLA2G2A; PLA2G4E; PLA2G2F;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	3	26	11.5384615384615	0.00543717259479681	0.0650226256884605	1	1	0.919479076634203	0.990430704160585	0.522949977299357
down	KRT76; EN1; TYRP1;	GO:0043473~pigmentation	3	26	11.5384615384615	0.00543717259479681	0.0650226256884605	1	1	0.919479076634203	0.990430704160585	0.522949977299357
down	SMIM22; CXCL11; CXCL10; INHA; HOXD13; FA2H; ACE2;	GO:0042127~regulation of cell population proliferation	7	163	4.29447852760736	0.00550861424781668	0.0650431430485372	1	1	0.921642556814519	0.990430704160585	0.523114989906473
down	DSCAM; EPHA8; NKX2-1; LHX2; GBX2; VAX1; DPYSL5; VSTM2L;	GO:0007411~axon guidance	8	206	3.88349514563107	0.00551339356883362	0.0650431430485372	1	1	0.921642556814519	0.990430704160585	0.523114989906473
up	JCHAIN; IGKV3-20; IGHM; IGHA2; LTF; CAMP; DEFA3; RNASE6;	GO:0019731~antibacterial humoral response	8	31	25.8064516129032	0.00553306859203651	0.46199573015568	1	1	0.999999999999988	0.999999999999988	1
up	LPXN; FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.00565978430692016	0.46199573015568	1	1	0.999999999999988	0.999999999999988	1
up	HP; SLC4A1; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	4	7	57.1428571428571	0.00565978430692016	0.46199573015568	1	1	0.999999999999988	0.999999999999988	1
down	FGF1; ANXA3; FLT4; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	4	54	7.40740740740741	0.00583189699966402	0.0683388735665328	1	1	0.930952077590423	0.990430704160585	0.549621181886912
down	NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	3	27	11.1111111111111	0.0059863265349922	0.0687639876980025	1	1	0.934740836045733	0.990430704160585	0.553040198314623
down	PLA2G2A; PLA2G4E; PLA2G2F;	GO:0036151~phosphatidylcholine acyl-chain remodeling	3	27	11.1111111111111	0.0059863265349922	0.0687639876980025	1	1	0.934740836045733	0.990430704160585	0.553040198314623
down	CLDN1; KRT14; CYP1A1; KRT16; MMP7; FOXG1; KRT33B;	GO:0007568~aging	7	166	4.21686746987952	0.00604713434643811	0.0690084743064114	1	1	0.937305823697907	0.990430704160585	0.555006502581233
up	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.00614202881802317	0.46199573015568	1	1	0.999999999999988	0.999999999999988	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.00614202881802317	0.46199573015568	1	1	0.999999999999988	0.999999999999988	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00614202881802317	0.46199573015568	1	1	0.999999999999988	0.999999999999988	1
down	BMP2; NR2E1; GATA5; GATA4;	GO:0045165~cell fate commitment	4	55	7.27272727272727	0.00619580240673556	0.0702459155984435	1	1	0.941462826853541	0.990430704160585	0.564958729036651
down	FLT4; GATA4; ISL1;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.00656744536783538	0.0716672475765036	1	1	0.94925052138089	0.990430704160585	0.576389911917863
down	KCNK2; CCNB1; GATA4; SOST;	GO:0009612~response to mechanical stimulus	4	57	7.01754385964912	0.006968164715764	0.0746405864645641	1	1	0.954638566059668	0.990430704160585	0.600303241894178
down	GBX2; FOXG1; DLX5; DLX6;	GO:0042472~inner ear morphogenesis	4	57	7.01754385964912	0.006968164715764	0.0746405864645641	1	1	0.954638566059668	0.990430704160585	0.600303241894178
down	HOXC11; HOXA11; FOXC2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.00718097590072053	0.0759877813494427	1	1	0.956987359486189	0.990430704160585	0.611138170920892
down	UQCRQ; EN2; EN1;	GO:0030901~midbrain development	3	29	10.3448275862069	0.00718097590072053	0.0759877813494427	1	1	0.956987359486189	0.990430704160585	0.611138170920892
down	RAMP2; FGF1; ANXA3; GATA4; ISL1; NR2E1;	GO:0045766~positive regulation of angiogenesis	6	131	4.58015267175572	0.00741022996078777	0.0779413344068401	1	1	0.960161446914004	0.990430704160585	0.626849786934583
down	LHX1; LHX3; EGFLAM;	GO:0008045~motor neuron axon guidance	3	30	10	0.00782733274230418	0.0785432354486385	1	1	0.965351508789215	0.990430704160585	0.631690627070032
down	CYP26A1; AKR7A3; DPEP1; AOC1; CYP2C18;	GO:0006805~xenobiotic metabolic process	5	94	5.31914893617021	0.00790862191003106	0.0786914087551875	1	1	0.966271565212548	0.990430704160585	0.632882323444574
down	CYP26C1; DMBX1; EMX2; ZIC5; VAX1; SPINK6;	GO:0007417~central nervous system development	6	133	4.51127819548872	0.00793223822503608	0.0786914087551875	1	1	0.967208503405116	0.990430704160585	0.632882323444574
down	HOXD9; HOXD10; HOXA11; DEFB126;	GO:0007338~single fertilization	4	61	6.55737704918033	0.0086978466792067	0.0857990977508186	1	1	0.976484191511542	0.990430704160585	0.690046514517464
down	GABRD; CLDN17; FXYD3; SLC26A9; SLC26A10;	GO:1902476~chloride transmembrane transport	5	97	5.15463917525773	0.00893782368523444	0.0876710121034794	1	1	0.979483672077284	0.990430704160585	0.705101544330018
up	IFNG; FGR; IL10; CLEC6A; IL26; CLEC4E; CD14;	GO:0050715~positive regulation of cytokine secretion	7	27	25.9259259259259	0.0090587708928489	0.605679487196869	1	1	0.999999999999988	0.999999999999988	1
down	SMIM22; CLDN1; FGF1; BMP2; NTF3; SERPINB3; TNFAIP6; FOXF1;	GO:0030335~positive regulation of cell migration	8	226	3.53982300884956	0.00922261029479865	0.0883248309365153	1	1	0.98174006953505	0.990430704160585	0.710359937701154
down	HOXD8; HOXC8; TCF15;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.00996704354754441	0.0935616023334007	1	1	0.984033854744244	0.990430704160585	0.75247711543932
down	BMP2; DLX5; GATA5;	GO:0071773~cellular response to BMP stimulus	3	33	9.09090909090909	0.00996704354754441	0.0935616023334007	1	1	0.984033854744244	0.990430704160585	0.75247711543932
down	CLDN7; CLDN1; MAOB; CLDN18; GGH;	GO:0045471~response to ethanol	5	100	5	0.0100558884587052	0.0938908088176432	1	1	0.984347741141291	0.990430704160585	0.755124786486722
up	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.010180863247838	0.628341995834512	1	1	0.999999999999988	0.999999999999988	1
up	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.010180863247838	0.628341995834512	1	1	0.999999999999988	0.999999999999988	1
down	FLT4; FOXF1; ABCA12;	GO:0048286~lung alveolus development	3	34	8.82352941176471	0.0107482397478669	0.0997389093964509	1	1	0.986379185688476	0.990430704160585	0.80215863097625
up	LY86; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.0109311605329114	0.644462803452707	1	1	0.999999999999988	0.999999999999988	1
down	CXCL11; RAMP2; CXCL10; ADGRG7; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	5	103	4.85436893203883	0.0112662481103074	0.102452443753108	1	1	0.987892811037358	0.990430704160585	0.823982460992187
up	IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-40; IGLV2-14; IGLV2-11; IGKC; IGHG2; IGKV3-11; IGKV4-1; IGHV4-34; IGLC2; IGLC3; TRDC; IGHV5-51; IGHV3-35; IGHD; TRBC2; TRBC1; IGHV3-74; IGHA2; IGHM;	GO:0006958~complement activation, classical pathway	22	161	13.6645962732919	0.0113672741095403	0.644462803452707	1	1	0.999999999999988	0.999999999999988	1
up	TESPA1; LCK; CCR7; TRAT1; CARD11;	GO:0050862~positive regulation of T cell receptor signaling pathway	5	15	33.3333333333333	0.0115130455124497	0.644462803452707	1	1	0.999999999999988	0.999999999999988	1
down	DEFB4A; LCE3A; PGLYRP4;	GO:0031640~killing of cells of other organism	3	35	8.57142857142857	0.0115638840482077	0.104614204912802	1	1	0.988704333061759	0.990430704160585	0.841368608312735
down	RAMP2; BMP2; WT1; ISL1; FOXF1; FOXC2; POPDC3;	GO:0007507~heart development	7	190	3.68421052631579	0.0118684041647961	0.106815637483165	1	1	0.989555930247859	0.990430704160585	0.859073816315457
down	AKR7A3; IDO1; GPX2; MAOB;	GO:0022900~electron transport chain	4	68	5.88235294117647	0.0123552339648483	0.108592334961902	1	1	0.990147102312816	0.990430704160585	0.873363056350533
down	CLDN7; ISL1; SOST;	GO:0031333~negative regulation of protein-containing complex assembly	3	37	8.10810810810811	0.0132994515210376	0.113272401735277	1	1	0.990430704160585	0.990430704160585	0.911002889977404
down	CCL21; SOX18; HES5;	GO:0048469~cell maturation	3	37	8.10810810810811	0.0132994515210376	0.113272401735277	1	1	0.990430704160585	0.990430704160585	0.911002889977404
down	SOX1; ASTN1; NKX2-1; CDK5R2; VAX1;	GO:0001764~neuron migration	5	109	4.58715596330275	0.0139769231608242	0.117343451927815	1	1	0.990430704160585	0.990430704160585	0.943744656143119
up	IL18RAP; EOMES; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	4	10	40	0.0144523927656957	0.756237160587597	1	1	0.999999999999988	0.999999999999988	1
up	PTPN6; NFAM1; FCRL3; CARD11;	GO:0045577~regulation of B cell differentiation	4	10	40	0.0144523927656957	0.756237160587597	1	1	0.999999999999988	0.999999999999988	1
up	HP; PPBP; IL10; GNLY; FPR2; CFP; SLC11A1; CAMP; IRF8; CLEC4D; STAB1; CLEC4E; IGHG2; IGLC3; TRBC1; TRBC2; IGHA2; IGLC2; IGHD; IGHV3-74; IGHV4-34; IGHV5-51; IGHV3-35; FCER1G; TRDC; IGKC; IGHM;	GO:0042742~defense response to bacterium	27	216	12.5	0.0149171029900808	0.758079109399857	1	1	0.999999999999988	0.999999999999988	1
down	BMP2; PAX3; LHX1; LHX3; EGFLAM;	GO:0009887~animal organ morphogenesis	5	111	4.5045045045045	0.0149697648385263	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0154324372083893	0.758079109399857	1	1	0.999999999999988	0.999999999999988	1
up	OXT; SLC4A1; AVPR2;	GO:0035811~negative regulation of urine volume	3	5	60	0.0154324372083893	0.758079109399857	1	1	0.999999999999988	0.999999999999988	1
down	CLDN5; FGF19; ROS1; BMP2; MIF; CCNB1; GATA5;	GO:0010629~negative regulation of gene expression	7	204	3.43137254901961	0.0167163338052581	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
up	LCK; CCL2; CCR2; SIRPG; SIRPB1;	GO:0050870~positive regulation of T cell activation	5	17	29.4117647058824	0.0173697982791864	0.798529866807022	1	1	0.999999999999988	0.999999999999988	1
up	IL10; CORO1A; CXCR5; CNR2; PPBP; IL16;	GO:0030595~leukocyte chemotaxis	6	24	25	0.0175829177153187	0.798529866807022	1	1	0.999999999999988	0.999999999999988	1
up	IL10; SLC11A1; IRF8; IRF4; BATF; GBP7;	GO:0042832~defense response to protozoan	6	24	25	0.0175829177153187	0.798529866807022	1	1	0.999999999999988	0.999999999999988	1
down	CLDN5; KRT16; MIF; DPEP1; NKX2-1;	GO:0030336~negative regulation of cell migration	5	116	4.31034482758621	0.0176553205039913	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	CA2; SLC26A9; SLC26A10;	GO:0015701~bicarbonate transport	3	42	7.14285714285714	0.0182549218579025	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	FGF19; BMP2; FLT4; KNDC1; ITLN1; TREM2;	GO:0001934~positive regulation of protein phosphorylation	6	161	3.72670807453416	0.0182617653936402	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	MMP7; MMP12; MMP13;	GO:0030574~collagen catabolic process	3	43	6.97674418604651	0.0193527000904514	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	GBX2; ISL1; ALX1;	GO:0001755~neural crest cell migration	3	44	6.81818181818182	0.0204862117130937	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
up	ITGB2; CD14; ITGAM; SCIMP; LY96;	GO:0034142~toll-like receptor 4 signaling pathway	5	18	27.7777777777778	0.0209220701047153	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	BMP2; ADRA2C; FOXG1; DUOXA1;	GO:0045666~positive regulation of neuron differentiation	4	81	4.93827160493827	0.02146845232126	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	MUC21; DSCAM; CLDN7;	GO:0007162~negative regulation of cell adhesion	3	45	6.66666666666667	0.0216554888034435	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.0219357270935514	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0219357270935514	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	FGR; FPR2; BTLA;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	3	6	50	0.0219357270935514	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	IFNG; FCER2; PRF1;	GO:0051712~positive regulation of killing of cells of other organism	3	6	50	0.0219357270935514	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	ACOD1; CD14; FCGR2B;	GO:0071219~cellular response to molecule of bacterial origin	3	6	50	0.0219357270935514	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0219357270935514	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0219357270935514	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	CHP2; DPEP1; LCE1D; ACER1;	GO:0071277~cellular response to calcium ion	4	82	4.8780487804878	0.0223016979508766	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	CCL21; CXCL11; DEFB4A; RAMP2; KCNK2; ADGRL2; GAST; CXCL10; SAA1; ADRA2C; SSTR5; ADRA1B; NMU; GPR158; ARHGEF25; OR2I1P; ADGRG7; FZD10; OR7C2; CGB7; GPR87; MRGPRX3; GNGT1;	GO:0007186~G protein-coupled receptor signaling pathway	23	1152	1.99652777777778	0.0226046316529676	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	CLDN5; SOX18; ISL1;	GO:0003151~outflow tract morphogenesis	3	46	6.52173913043478	0.0228605438243979	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	CXCL14; BMP2; LHX3;	GO:0048839~inner ear development	3	46	6.52173913043478	0.0228605438243979	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
up	F13A1; IL2RA; ITGB2; FCER2; HCK; VIM; ALOX5; ITGAM; CCL2; OSM; FPR1; IL10; IL32; PRTN3; PTAFR; PTPN6; CD80; FLT3; CCR2; FASLG; CCR5; IL5RA; IL10RA; IL16; IRF4; BATF; INPP5D; CSF3R; IL22; IL26; IFNA5; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	32	278	11.5107913669065	0.0230371217415601	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	KLK8; KCNK2; JPH3; NTF3;	GO:0007613~memory	4	83	4.81927710843374	0.0231544116550013	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
up	MEFV; IL10; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	4	12	33.3333333333333	0.023447087035962	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	IL2RA; CTLA4; FCGR2B; INPP5D;	GO:0050777~negative regulation of immune response	4	12	33.3333333333333	0.023447087035962	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	HTRA3; RBPMS2; SOST;	GO:0030514~negative regulation of BMP signaling pathway	3	47	6.38297872340426	0.0241013702686534	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
down	EN2; EN1; ISL2;	GO:0048666~neuron development	3	47	6.38297872340426	0.0241013702686534	0.11910816315715	1	1	0.990430704160585	0.990430704160585	0.957937495751633
up	MS4A1; CD79A; IL10; CD40LG; CD70; CARD11; IFNA5;	GO:0042100~B cell proliferation	7	34	20.5882352941176	0.0245549075512701	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	GATA4; RASIP1; TREM2;	GO:0010507~negative regulation of autophagy	3	48	6.25	0.0253779432865596	0.119756456698198	1	1	0.990430704160585	0.990430704160585	0.963151451493724
down	BMP2; INHBE; INHA;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	3	48	6.25	0.0253779432865596	0.119756456698198	1	1	0.990430704160585	0.990430704160585	0.963151451493724
down	RAMP2; IDO1; ADRA2C; PSG7;	GO:0007565~female pregnancy	4	86	4.65116279069767	0.0258302553424912	0.121562333768166	1	1	0.990430704160585	0.990430704160585	0.97767537086404
down	ASTN1; DSCAM; C1QL1; NKX2-1;	GO:0007626~locomotory behavior	4	87	4.59770114942529	0.0267617068314616	0.125607365934763	1	1	0.990430704160585	0.990430704160585	1
up	LILRA5; LPL; ORM2; NLRP12; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	7	35	20	0.0277096210399617	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	HOXD9; HOXD10; POPDC3;	GO:0007519~skeletal muscle tissue development	3	50	6	0.0280381416037894	0.129853037772457	1	1	0.990430704160585	0.990430704160585	1
up	CRYBA1; IL10; SLC11A1; CLEC4A;	GO:0001818~negative regulation of cytokine production	4	13	30.7692307692308	0.0289709400167559	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	FPR3; FPR1; FPR2; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	4	13	30.7692307692308	0.0289709400167559	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	APOA2; TREM1; HP; HPR;	GO:0002526~acute inflammatory response	4	13	30.7692307692308	0.0289709400167559	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	NEFH; NCKAP1L; PARVG; CYFIP2; RAC2;	GO:0030031~cell projection assembly	5	20	25	0.0293671959769763	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	INHA; WT1; HOXA11; GATA4;	GO:0008584~male gonad development	4	90	4.44444444444444	0.0296755450326143	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
up	TMOD1; LMOD3; LMOD2;	GO:0051694~pointed-end actin filament capping	3	7	42.8571428571429	0.0297014512936136	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	PRKCB; MS4A1; CD79A; CXCR5; FCRL1; LAT2;	GO:0042113~B cell activation	6	28	21.4285714285714	0.0312796471201227	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	LRAT; LY6G6C; BMP2; FER1L6;	GO:0009617~response to bacterium	4	92	4.34782608695652	0.0317182430185223	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
down	CYP1A1; HMGCS2; ACER1; PSAPL1;	GO:0019216~regulation of lipid metabolic process	4	92	4.34782608695652	0.0317182430185223	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
down	HOXB8; NMU; ALOXE3;	GO:0019233~sensory perception of pain	3	53	5.66037735849057	0.0322949294683252	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
down	FOXF1; IL1F10; CRNN;	GO:0071345~cellular response to cytokine stimulus	3	53	5.66037735849057	0.0322949294683252	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
up	IFNG; APOA2; FPR2; FCGR2B; SLC11A1; FCER1G; SIRPB1; SIRPG;	GO:0050766~positive regulation of phagocytosis	8	45	17.7777777777778	0.0331090420411523	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	CYP26A1; CA2; WT1; LHX1;	GO:0001822~kidney development	4	94	4.25531914893617	0.033841481474197	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
up	LILRA5; IFNG; LPL; AIF1; IL16; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	7	37	18.9189189189189	0.0348178426504259	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	DEFB4A; PLA2G2A; LCE3A; PGLYRP4;	GO:0050830~defense response to Gram-positive bacterium	4	95	4.21052631578947	0.0349333913504131	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
up	P2RY10; GPR171; PTAFR; P2RY13;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.0352006877232802	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	CD3E; CD80; IRF4; CARD11;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	4	14	28.5714285714286	0.0352006877232802	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	NPNT; LYPD5; MSLNL; LYPD3;	GO:0007160~cell-matrix adhesion	4	96	4.16666666666667	0.0360455313085026	0.133459789543459	1	1	0.990430704160585	0.990430704160585	1
down	ELANE; HES5; RBPMS2;	GO:0048661~positive regulation of smooth muscle cell proliferation	3	57	5.26315789473684	0.0384632828784106	0.137899162024035	1	1	0.990430704160585	0.990430704160585	1
up	AQP9; SLC14A1; AQP10;	GO:0071918~urea transmembrane transport	3	8	37.5	0.0387170764136044	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	PTAFR; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0387170764136044	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	TRAV19; TRBV12-3; TRAV8-4; TRBC1; HLA-DQA2; CD3D; TRBV7-9; TRAV29DV5; HLA-DQB2; LCK; CD3E; CD3G; CD247; TRAT1; SKAP1; PSMA8; INPP5D; CARD11; PRAM1; HHLA2; CTLA4;	GO:0050852~T cell receptor signaling pathway	21	174	12.0689655172414	0.0388268899048033	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	LILRA5; IFNG; LPL; ORM2; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	5	22	22.7272727272727	0.0396911702717146	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	PAX7; DLX2; HES5;	GO:0051216~cartilage development	3	58	5.17241379310345	0.0400923407144191	0.143151793225717	1	1	0.990430704160585	0.990430704160585	1
down	BMP2; INHA; INHBE;	GO:0060395~SMAD protein signal transduction	3	59	5.08474576271187	0.0417558269289575	0.146501324739397	1	1	0.990430704160585	0.990430704160585	1
down	FGF1; ELANE; MIF;	GO:0043406~positive regulation of MAP kinase activity	3	60	5	0.0434535405627317	0.146501324739397	1	1	0.990430704160585	0.990430704160585	1
down	TSPAN15; SAA1; MMP13; NOTUM; AMTN; PAPPA2;	GO:0044267~cellular protein metabolic process	6	200	3	0.0441447457725607	0.146501324739397	1	1	0.990430704160585	0.990430704160585	1
up	LCK; FES; HCK; FGR; BLK; SLA;	GO:0038083~peptidyl-tyrosine autophosphorylation	6	31	19.3548387096774	0.0451669618510402	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
down	KLK8; NYAP1; NTF3;	GO:0048812~neuron projection morphogenesis	3	62	4.83870967741935	0.0469507897044688	0.146501324739397	1	1	0.990430704160585	0.990430704160585	1
down	AKR1B10; LRAT; RBP1;	GO:0001523~retinoid metabolic process	3	63	4.76190476190476	0.0487498680833848	0.146501324739397	1	1	0.990430704160585	0.990430704160585	1
down	FOLR1; SOX18; GATA4;	GO:0001947~heart looping	3	63	4.76190476190476	0.0487498680833848	0.146501324739397	1	1	0.990430704160585	0.990430704160585	1
up	SLC11A1; TRPC3; TRPC5;	GO:0006828~manganese ion transport	3	9	33.3333333333333	0.048951169895348	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	AVPR2; FLI1; NFE2;	GO:0007599~hemostasis	3	9	33.3333333333333	0.048951169895348	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
up	MAJIN; MEI1; TERB1;	GO:0045141~meiotic telomere clustering	3	9	33.3333333333333	0.048951169895348	0.811988847042168	1	1	0.999999999999988	0.999999999999988	1
